I'm LongbridgeAI, I can summarize articles.Hepion Pharmaceuticals director Gary S. Stetz II filed an initial Form 3 beneficial ownership statement on July 10, 2026, covering a reporting event dated July 1. The disclosure was published via EDGAR by Hepion Pharmaceuticals Inc.
- Hepion Pharmaceuticals director Gary S. Stetz II filed an initial Form 3 on July 10 for a July 1 reporting event. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hepion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-032890), on July 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here